← Leaderboards
Katherine Elizabeth Hekman
Northwestern University At Chicago
$129,939
Attributed
$129,939
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $66.9K · FY2017–25$100K$75K$50K$25K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$129,939 · 1
VA$0 · 2
By mechanism
F32$129,939 · 1
I21$0 · 1
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Roberta Goncalves Marangoni$231,750
- Melissa Ann Thal$61,393
- Jason A Wertheim$3,966,143
- Connor William Lantz$85,432
- Melina Rae Kibbe$9,200,692
Others in their field
Other Emerging Leaders on “Technology”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$436,612,396
- Valerie Koch · University Corporation For Atmospheric Res$252,793,840
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
Research focus
TechnologyBlood VesselsCell TherapyTissuesLimb StructureSourceStem CellsEndothelial CellsCellsInduced Pluripotent Stem CellAdverse EventLimb IschemiaDisabilityAmputationLimb LossModalityCell LineImplantationIn VitroCell AgingAnimal ModelBlood PlateletsHydrogelsAdverse Outcome
Grant awards (6)
Improving Induced Pluripotent Stem Cell-Derived Endothelial Cells as Therapy for Peripheral Arterial Disease$0
IK2 · FY2025 · VA · contact PI
Applying induced pluripotent stem cell derived endothelial cells to regenerative therapy in chronic limb threatening ischemia$0
I21 · FY2025 · VA · contact PI
Applying induced pluripotent stem cell derived endothelial cells to regenerative therapy in chronic limb threatening ischemia$0
I21 · FY2024 · VA · contact PI
Applying induced pluripotent stem cell derived endothelial cells to regenerative therapy in chronic limb threatening ischemia$0
I21 · FY2023 · VA · contact PI
Modulating senescence in induced pluripotent stem cell-derived endothelial cells for vascular disease modeling and therapy$66,861
F32 · FY2018 · HL · contact PI
Modulating senescence in induced pluripotent stem cell-derived endothelial cells for vascular disease modeling and therapy$63,078
F32 · FY2017 · HL · contact PI